CymaBay Therapeutics Alternatives & Competitors
12 companies similar to CymaBay Therapeutics — Dedicated to improving the lives of patients with liver diseases
Companies similar to CymaBay Therapeutics
Mirum Pharmaceuticals, Inc.
Creating transformative medicine for people with rare liver disease.
Foster City, United State...
HighTide Therapeutics
East Meets West—The Quest for Cure
Shenzhen, China
Ocera Therapeutics
Dedicated to Innovation in Liver Disease Treatment, Pioneering Life-Saving Therapeutics fo...
89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-...
San Francisco, United Sta...
Track all CymaBay Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver dise...
Morristown, United States
Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sen...
Minneapolis, United State...
COUR Pharma
Reprogramming the immune system to restore health in people suffering from autoimmune dise...
Evanston, United States
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Afferent Pharmaceuticals
Advancing the science of chronic pain relief by targeting P2X3 receptors in nerve fibers
About CymaBay Therapeutics
CymaBay Therapeutics is a United States-based clinical-stage biopharmaceutical company, founded in 1991, with a focused mission, as expressed in their slogan: "Dedicated to improving the lives of patients with liver diseases." The company operates primarily within the Biopharma, Biotechnology, and Pharmaceutical indust...
Scientific Research, Development of Transformative Therapies, Clinical Trials Management, Global Medicine Distribution, Public Health Preparedness
Healthcare Providers, Patients with Infectious Diseases, Cancer Patients, Pharmaceutical Distributors, Research Institutions
Biopharmaceutical Company, Clinical-stage, Liver Diseases, Autoimmune Liver Disease, Therapies, PPARδ Agonist, Primary Biliary Cholangitis, Investigational Products, Chronic Diseases, San Francisco Bay Area, Proprietary Medicines, Gout, Uric Acid, Phase 2 Studies, Metabolic Disease
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches CymaBay Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at CymaBay Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
